LiveWire Ergogenics, Inc.
LVVV · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.14 | 0.15 | -0.08 | -0.05 |
| FCF Yield | 11.05% | 19.43% | 6.32% | -3.66% |
| EV / EBITDA | 13.86 | 5.61 | 8.80 | -5.76 |
| Quality | ||||
| ROIC | 1.81% | 12.85% | 12.34% | -66.20% |
| Gross Margin | 93.77% | 97.55% | 93.14% | 82.42% |
| Cash Conversion Ratio | 1.58 | 0.74 | 0.58 | 3.65 |
| Growth | ||||
| Revenue 3-Year CAGR | -46.06% | 24.28% | 49.47% | 35.23% |
| Free Cash Flow Growth | -81.72% | 72.15% | 184.84% | -248.16% |
| Safety | ||||
| Net Debt / EBITDA | 10.36 | 2.73 | 2.93 | -0.99 |
| Interest Coverage | 0.53 | 3.38 | 2.59 | -4.11 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 68.74 |
| Cash Conversion Cycle | -17,003.37 | -10,231.63 | -1,792.90 | -307.90 |